AAAAAA
Results:
1-16
|
Results: 16
Authors:
MCDONALD AC
VASEY PA
ADAMS L
WALLING J
WOODWORTH JR
ABRAHAMS T
MCCARTHY S
BAILEY NP
SIDDIQUI N
LIND MJ
CALVERT AH
TWELVES CJ
CASSIDY J
KAYE SB
Citation: Ac. Mcdonald et al., A PHASE-I AND PHARMACOKINETIC STUDY OF LY231514, THE MULTITARGETED ANTIFOLATE, Clinical cancer research, 4(3), 1998, pp. 605-610
Authors:
MCDONALD AC
VASEY PA
ADAMS L
WALLING J
WOODWORTH JR
ABRAHAMS T
MCCARTHY S
BAILEY NP
SIDDIQUI N
LIND MJ
CALVERT AH
TWELVES CJ
CASSIDY J
KAYE SB
Citation: Ac. Mcdonald et al., A PHASE-I AND PHARMACOKINETIC STUDY OF LY231514, THE MULTITARGETED ANTIFOLATE, Clinical cancer research, 4(3), 1998, pp. 605-610
Authors:
WALLING J
Citation: J. Walling, THE ANTIMETABOLITE RESURGENCE IN THE TREATMENT OF METASTATIC BREAST-CANCER, Journal of women's health, 7(5), 1998, pp. 622-622
Authors:
NIYIKIZA C
BAKER S
JOHNSON R
WALLING J
SEITZ D
ALLEN R
Citation: C. Niyikiza et al., MTA (LY231514) - RELATIONSHIP OF VITAMIN METABOLITE PROFILE, DRUG EXPOSURE, AND OTHER PATIENT CHARACTERISTICS TO TOXICITY, Annals of oncology, 9, 1998, pp. 609-609
Authors:
HAMMOND L
VILLALONACALERO M
ECKHARDT SG
SIU L
HIDALGO M
THORNTON D
WALLING J
BAKER S
COLTMAN C
VONHOFF D
ROWINSKY E
Citation: L. Hammond et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF THE MULTITARGETED ANTIFOLATE (MTA, LY231514) WITH FOLIC-ACID (FA), Annals of oncology, 9, 1998, pp. 620-620
Authors:
AYLESWORTH C
BAKER SD
STEPHENSON J
BRITTEN C
MONROE P
WALLING J
JOHNSON R
VONHOFF D
ROWINSKY E
Citation: C. Aylesworth et al., PHASE-I AND PHARMACOKINETIC (PK) STUDY OF THE GLYCINAMIDE RIBONUCLEOTIDE FORMYLTRANSFERASE INHIBITOR LY309887 AS A BOLUS EVERY 3 WEEKS WITHFOLIC-ACID, Annals of oncology, 9, 1998, pp. 610-610
Authors:
ORTIZBUTCHER C
PENNELL JP
WALLING J
ZJACIC B
FLETCHER MA
Citation: C. Ortizbutcher et al., ANALYSIS OF HEMODIALYSIS ULTRAFILTRATE BY RT-PCR FOR HIV PROTEINS AFTER AN ACCIDENTAL SPLASH OF A DIALYSIS PROVIDER, Journal of the American Society of Nephrology, 8, 1997, pp. 1144-1144
Authors:
CARMICHAEL J
WALLING J
Citation: J. Carmichael et J. Walling, ADVANCED BREAST-CANCER - INVESTIGATIONAL ROLE OF GEMCITABINE, European journal of cancer, 33, 1997, pp. 27-30
Authors:
CARMICHAEL J
ALLERHEILIGEN S
WALLING J
Citation: J. Carmichael et al., A PHASE-I STUDY OF GEMCITABINE AND CARBOPLATIN IN NONSMALL CELL LUNG-CANCER, Seminars in oncology, 23(5), 1996, pp. 55-59
Authors:
CARMICHAEL J
WALLING J
Citation: J. Carmichael et J. Walling, PHASE-II ACTIVITY OF GEMCITABINE IN ADVANCED BREAST-CANCER, Seminars in oncology, 23(5), 1996, pp. 77-81
Authors:
ANDERSON H
THATCHER N
WALLING J
HANSEN H
Citation: H. Anderson et al., A PHASE-I STUDY OF A 24-HOUR INFUSION OF GEMCITABINE IN PREVIOUSLY UNTREATED PATIENTS WITH INOPERABLE NON-SMALL-CELL LUNG-CANCER, British Journal of Cancer, 74(3), 1996, pp. 460-462
Authors:
PATARCA R
KLIMAS NG
WALLING J
YUE XS
GARCIA MN
PONS H
SANDLER D
FRIEDLANDER A
FLETCHER MA
Citation: R. Patarca et al., CD8 T-CELL IMMUNOTHERAPY IN AIDS - LESSONS LEARNED AT THE CELLULAR AND MOLECULAR-BIOLOGY LEVELS, The FASEB journal, 9(4), 1995, pp. 1051-1051
Authors:
CARMICHAEL J
POSSINGER K
PHILLIP P
BEYKIRCH M
KERR H
WALLING J
HARRIS AL
Citation: J. Carmichael et al., ADVANCED BREAST-CANCER - A PHASE-II TRIAL WITH GEMCITABINE, Journal of clinical oncology, 13(11), 1995, pp. 2731-2736
Authors:
WALLING J
Citation: J. Walling, CHEMOTHERAPY FOR ADVANCED NON-SMALL-CELL LUNG-CANCER, Respiratory medicine, 88(9), 1994, pp. 649-657
Authors:
ANDERSON H
LUND B
BACH F
THATCHER N
WALLING J
HANSEN HH
Citation: H. Anderson et al., SINGLE-AGENT ACTIVITY OF WEEKLY GEMCITABINE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY, Journal of clinical oncology, 12(9), 1994, pp. 1821-1826
Authors:
KLIMAS N
PATARCA R
WALLING J
GARCIA R
MAYER V
MOODY D
OKARMA T
FLETCHER MA
Citation: N. Klimas et al., CLINICAL AND IMMUNOLOGICAL CHANGES IN AIDS PATIENTS FOLLOWING ADOPTIVE THERAPY WITH ACTIVATED AUTOLOGOUS CD8 T-CELLS AND INTERLEUKIN-2 INFUSION, AIDS, 8(8), 1994, pp. 1073-1081
Risultati:
1-16
|